Phathom Pharmaceuticals, Inc.
PHAT
$3.24
-$0.075-2.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 212.32M | 297.26M | 334.68M | 276.24M | 322.23M |
| Total Receivables | 36.36M | 38.80M | 21.05M | 10.88M | 3.88M |
| Inventory | 3.17M | 3.21M | 3.11M | 2.18M | 1.46M |
| Prepaid Expenses | 13.06M | 20.87M | 14.98M | 15.50M | 12.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 264.90M | 360.13M | 373.82M | 304.79M | 340.31M |
|
|
|||||
| Total Current Assets | 264.90M | 360.13M | 373.82M | 304.79M | 340.31M |
| Net Property, Plant & Equipment | 1.74M | 2.09M | 2.49M | 2.86M | 3.23M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.57M | 16.10M | 10.74M | 11.73M | 12.96M |
| Total Assets | 294.21M | 378.32M | 387.04M | 319.38M | 356.50M |
|
|
|||||
| Total Accounts Payable | 11.62M | 10.51M | 7.13M | 7.66M | 8.40M |
| Total Accrued Expenses | 44.83M | 54.94M | 37.28M | 28.72M | 17.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.58M | 20.28M | 20.87M | 10.63M | 17.21M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 74.03M | 85.73M | 65.29M | 47.01M | 43.46M |
|
|
|||||
| Total Current Liabilities | 74.03M | 85.73M | 65.29M | 47.01M | 43.46M |
| Long-Term Debt | 547.05M | 534.67M | 498.12M | 495.61M | 451.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 133.00K | 292.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.50M | 11.50M | 10.75M | 10.45M | 9.70M |
| Total Liabilities | 632.58M | 631.90M | 574.16M | 553.21M | 505.00M |
|
|
|||||
| Common Stock & APIC | 1.02B | 1.01B | 1.00B | 869.15M | 863.03M |
| Retained Earnings | -1.36B | -1.26B | -1.19B | -1.10B | -1.01B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -338.38M | -253.58M | -187.11M | -233.83M | -148.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -338.38M | -253.58M | -187.11M | -233.83M | -148.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -338.38M | -253.58M | -187.11M | -233.83M | -148.50M |
|
|
|||||